GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Activity

21 hedge funds and large institutions have $19.5M invested in Galmed Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
-3
Holders Change %
-12.5%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
4
Increased
6
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
California Public Employees Retirement System
1
California Public Employees Retirement System
California
$265K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$360K
3
Morgan Stanley
3
Morgan Stanley
New York
$505K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$33K
5
UBS Group
5
UBS Group
Switzerland
$32K

Top Sellers

1
PF
1
Phoenix Financial
Israel
$0
2
NCM
2
Nantahala Capital Management
Connecticut
$5.99M
3
VC
3
Voss Capital
Texas
$0
4
RJA
4
Raymond James & Associates
Florida
$437K
5
EMG
5
ETF Managers Group
New Jersey
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
FDCDDQ
26
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$3.53K -6 Closed
FHA
27
Flagship Harbor Advisors
Massachusetts
– -$1K -2 Closed
1
2